Your browser doesn't support javascript.
loading
Decitabine in combination with idarubicin within a modified busulfan/cyclophosphamide conditioning regimen for patients with advanced myelodysplastic syndrome: A prospective multicenter clinical cohort study.
Cao, Yigeng; Wang, Mingyang; Wang, Fuxu; Guo, Wenwen; Ma, Yueshen; Li, Xiaoyun; He, Yi; Pang, Aiming; Zhang, Rongli; Zhai, Weihua; Chen, Xin; Ma, Qiaoling; Wei, Jialin; Yang, Donglin; Huang, Yong; Feng, Dan; Liu, Jia; Gao, Xin; Wen, Shupeng; Wang, Wen; Wang, Tao; Li, Ying; Fang, Xiaosheng; Li, Yingchun; Zhang, Xiaohan; Cai, Yun; Wang, Yongqi; Cao, Weijie; Lu, Runqing; Feng, Sizhou; Guo, Rong; Fu, Yuewen; Du, Xin; Liu, Zhuogang; Wang, Xin; Wang, Ling; Ma, Liangming; Liu, Chuanfang; Zhang, Xuejun; Han, Mingzhe; Jiang, Erlie.
Affiliation
  • Cao Y; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Wang M; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Wang F; Department of Hematology, Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, Hebei 050000, China.
  • Guo W; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Ma Y; Center for Information and Resource, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Ti
  • Li X; Center for Information and Resource, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Ti
  • He Y; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Pang A; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Zhang R; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Zhai W; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Chen X; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Ma Q; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Wei J; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Yang D; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Huang Y; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Feng D; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Liu J; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Gao X; Center for Information and Resource, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Ti
  • Wen S; Department of Hematology, Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, Hebei 050000, China.
  • Wang W; Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250000, China.
  • Wang T; Department of Hematology, Shanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi 030032, China.
  • Li Y; Department of Hematology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, Shandong 266042, China.
  • Fang X; Department of Hematology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250000, China.
  • Li Y; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250000, China.
  • Zhang X; Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110000, China.
  • Cai Y; Department of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, Shenzhen, Guangdong 518000, China.
  • Wang Y; Department of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, Shenzhen, Guangdong 518000, China.
  • Cao W; Department of Hematology, Henan Cancer Hospital, Cancer Hospital Affiliated Zhengzhou University, Zhengzhou, Henan 450000, China.
  • Lu R; Department of Hematology, Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China.
  • Feng S; Department of Hematology, Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China.
  • Guo R; Department of Hematopoietic Stem Cell Transplantation Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking
  • Fu Y; Department of Hematology, Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China.
  • Du X; Department of Hematology, Henan Cancer Hospital, Cancer Hospital Affiliated Zhengzhou University, Zhengzhou, Henan 450000, China.
  • Liu Z; Department of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, Shenzhen, Guangdong 518000, China.
  • Wang X; Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110000, China.
  • Wang L; Department of Hematology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250000, China.
  • Ma L; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250000, China.
  • Liu C; Department of Hematology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, Shandong 266042, China.
  • Zhang X; Department of Hematology, Shanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi 030032, China.
  • Han M; Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250000, China.
  • Jiang E; Department of Hematology, Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, Hebei 050000, China.
Chin Med J (Engl) ; 137(9): 1115-1117, 2024 May 05.
Article in En | MEDLINE | ID: mdl-38310445

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Busulfan / Idarubicin / Cyclophosphamide / Decitabine Type of study: Clinical_trials / Etiology_studies / Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Chin Med J (Engl) Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Busulfan / Idarubicin / Cyclophosphamide / Decitabine Type of study: Clinical_trials / Etiology_studies / Observational_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Chin Med J (Engl) Year: 2024 Document type: Article